Allen Chudzinski, MD
Colon & Rectal Surgery · Tampa, FLNPI 1750526273
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $162,666 of the $251,724 with a category attached, or 64.6%. 35 manufacturers reported payments, led by Baxter Healthcare at 53.6% of the total. 2025 is the largest year on record at $72,730, 5.0 times the $14,426 reported in 2019. Among colon & rectal surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 358 payments — averaging $703.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Baxter Healthcare$135K
- Johnson & Johnson$44K
- THD America, Inc.$27K
- Medical Device Business Services, Inc.$20K
- Intuitive Surgical$17K
- Medtronic$3K
- plus $5K from 29 others
Across 50 payments — averaging $2679.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$78K
- Ethicon Endo-surgery Inc.$56K
What the payments were for
- Consulting fees$162,66665%
- Speaking & faculty fees$23,8899%
- Travel & lodging$17,6027%
- Food & beverage$16,8517%
- Education$30,69312%
- Gifts$220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Baxter Healthcare | 102 | $135,023 |
| Johnson & Johnson(2 entities) | 48 | $44,076 |
| THD America, Inc. | 32 | $27,045 |
| Medical Device Business Services, Inc. | 23 | $20,140 |
| Intuitive Surgical | 67 | $16,949 |
| Medtronic | 29 | $3,420 |
| Gyrus ACMI, Inc. | 1 | $1,800 |
| Integra Lifesciences Corporation | 6 | $476 |
| Virtual Incision Corporation | 2 | $418 |
| Aroa Biosurgery Incorporated | 6 | $411 |
| Conmed Corporation | 3 | $278 |
| Boston Scientific | 5 | $252 |
| KCI USA, Inc. | 3 | $148 |
| Solventum Corporation | 3 | $143 |
| Organogenesis Inc. | 1 | $138 |
| Lumendi LLC | 2 | $137 |
| Coloplast | 1 | $127 |
| Hologic Sales And Service, LLC | 2 | $125 |
| Axonics, Inc. | 5 | $100 |
| Acell, Inc. | 1 | $98 |
| Mimedx Group, Inc. | 1 | $62 |
| Vioptix Inc | 1 | $53 |
| Davol Inc. | 1 | $49 |
| Stryker | 1 | $39 |
| Shire North American Group Inc | 2 | $33 |
| Innovation Technologies Inc | 1 | $24 |
| LSI Solutions Inc | 1 | $24 |
| QOL Medical, LLC | 1 | $23 |
| Zyla Life Sciences, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Merck | 1 | $16 |
| TELA Bio, Inc. | 1 | $15 |
| Portola Pharmaceuticals, LLC | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
| Hollister Incorporated | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TISSEEL$88,513
- FLOSEAL$37,225
- Echelon Circular$25,207
- Echelon Flex$17,286
- ECHELON ENDOPATH$16,810
- DERMABOND$16,661
- Da Vinci Surgical System$13,407
- No Related Product$6,103
- SEPRAFILM$3,507
- PerClot$3,023
- PERI-STRIPS DRY$2,790
- DA VINCI SP$2,500
- Signia$866
- INTEGRA$715
- Mira!$418
- INTERSTIM$325
- EEA$307
- INTEGRA DERMAL REGENERATION TEMPLATE$274
- PRIMATRIX$167
- DERMABOND PRINEO$158
How this compares
$251,724 in reported general payments places this provider in the 95th percentile of 157 colon & rectal surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin Sulfate | 51 | $243 |
| Metronidazole | 58 | $112 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Tampa
- Cesar SantiagoTampa$193K
- Jaime SanchezTampa$157K
- Jorge MarcetTampa$74K
- Gavin SigleTampa$15K
- Robert BennettTampa$14K
- Julian SanchezTampa$12K
- Mark SolimanAltamonte Springs$872K
- Eduardo Parra DavilaWest Palm Beach$577K
- Matthew AlbertAltamonte Springs$514K
- Avraham BelizonBoca Raton$482K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.